SequelSEC

CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL

Services-Commercial Physical & Biological Research · CIK 0001100682 · Fiscal year ends 1227

Revenue
$4.02B
Fiscal year ended 2025-12-27
Operating income
$25.16M
Fiscal year ended 2025-12-27
Free cash flow
Unavailable
Fiscal year ended 2025-12-27

CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) reported revenue of $4.02B and net income of -$144.34M for the fiscal year ended 2025-12-27. This page shows 10 annual periods of income statement, balance sheet and cash flow figures normalized from CHARLES RIVER LABORATORIES INTERNATIONAL, INC.’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Services-Commercial Physical & Biological Research.

Income

CHARLES RIVER LABORATORIES INTERNATIONAL, INC. income by fiscal year, in US dollars, normalized from SEC filings.
Metric2025-12-272024-12-282023-12-302022-12-312021-12-252020-12-262019-12-282018-12-292017-12-302016-12-31
Revenue$4.02B$4.05B$4.13B$3.98B$3.54B$2.92B$2.62B$2.27B$1.86B$1.68B
Cost of revenueUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable$289.67M$277.03M
Gross profitUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Operating income$25.16M$227.35M$617.26M$650.98M$589.86M$432.73M$351.15M$331.38M$288.28M$237.55M
Net income-$144.34M$22.20M$474.62M$486.23M$390.98M$364.30M$252.02M$226.37M$123.36M$154.76M
Research & developmentUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Weighted-average diluted sharesshares 49.56Mshares 51.63Mshares 51.45Mshares 51.30Mshares 51.42Mshares 50.61Mshares 49.69Mshares 49.02Mshares 48.56Mshares 47.96M
Pretax income-$99.50M$93.11M$581.28M$622.99M$480.71M$447.11M$304.08M$281.68M$296.96M$222.92M
Income tax expense$42.66M$67.82M$100.91M$130.38M$81.87M$81.81M$50.02M$54.46M$171.37M$66.84M
Diluted EPS$-2.91$0.20$9.22$9.48$7.60$7.20$5.07$4.62$2.54$3.23
Selling, general & administrative$743.07M$751.00M$747.86M$665.10M$619.92M$528.94M$517.62M$443.85M$371.27M$364.71M
General & administrativeUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Selling & marketingUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable

Balance

CHARLES RIVER LABORATORIES INTERNATIONAL, INC. balance by fiscal year, in US dollars, normalized from SEC filings.
Metric2025-12-272024-12-282023-12-302022-12-312021-12-252020-12-262019-12-282018-12-292017-12-302016-12-31
Cash & equivalents$213.77M$194.61M$276.77M$233.91M$241.21M$228.42M$238.01M$195.44M$163.79M$117.63M
Total assets$7.14B$7.53B$8.20B$7.60B$7.02B$5.49B$4.69B$3.86B$2.93B$2.71B
Current assets$1.45B$1.40B$1.61B$1.44B$1.27B$1.20B$1.02B$897.84M$826.62M$656.83M
Total liabilities$3.92B$4.02B$4.54B$4.58B$4.43B$3.35B$3.03B$2.52B$1.87B$1.86B
Current liabilities$1.12B$994.10M$1.06B$1.09B$1.03B$839.75M$710.18M$558.22M$463.50M$429.59M
Total equity incl. NCI$3.17B$3.47B$3.60B$2.98B$2.54B$2.12B$1.64B$1.32B$1.05B$839.12M
Temporary (mezzanine) equity$41.26M$41.13M$56.72M$42.43M$53.01M$25.50M$28.65M$18.52M$16.61M$14.66M
Inventory$299.10M$278.54M$380.26M$255.81M$199.15M$185.70M$160.66M$127.89M$114.96M$95.83M
Accounts receivable$708.86M$720.92M$780.38M$752.39M$642.88M$617.74M$514.03M$472.25M$430.02M$364.05M
Goodwill$2.76B$2.85B$3.10B$2.85B$2.71B$1.81B$1.54B$1.25B$804.91M$787.52M
Long-term debt$2.14B$2.24B$2.65B$2.71B$2.66B$1.93B$1.85B$1.64B$1.09B$1.19B
Accounts payable$148.80M$140.34M$168.94M$205.92M$198.13M$122.48M$111.50M$66.25M$77.84M$68.48M

Cash flow

CHARLES RIVER LABORATORIES INTERNATIONAL, INC. cash flow by fiscal year, in US dollars, normalized from SEC filings.
Metric2025-12-272024-12-282023-12-302022-12-312021-12-252020-12-262019-12-282018-12-292017-12-302016-12-31
Operating cash flow$737.65M$734.58M$683.90M$619.64M$760.80M$546.58M$480.94M$441.14M$318.07M$316.90M
Capital expendituresUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Investing cash flow-$209.32M-$245.09M-$563.16M-$607.92M-$1.44B-$601.54M-$681.50M-$955.00M-$72.59M-$692.67M
Financing cash flow-$536.73M-$550.93M-$85.52M-$42.40M$672.60M$47.25M$231.94M$558.06M-$208.48M$380.76M
Net change in cash$10.43M-$78.91M$43.27M-$5.10M$13.20M-$6.93M$42.73M$30.99M$46.44M-$69.00K
Stock-based compensation$71.08M$69.89M$72.05M$73.62M$71.47M$56.34M$57.27M$47.35M$44.00M$43.64M
Common dividends paidUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Common share repurchases$360.67M$119.18M$24.16M$38.65M$40.71M$23.98M$18.09M$13.85M$106.91M$12.27M
Depreciation & amortization$403.31M$361.74M$314.12M$303.87M$265.54M$234.92M$198.10M$161.78M$131.16M$126.66M

Derived

CHARLES RIVER LABORATORIES INTERNATIONAL, INC. derived by fiscal year, in US dollars, normalized from SEC filings.
Metric2025-12-272024-12-282023-12-302022-12-312021-12-252020-12-262019-12-282018-12-292017-12-302016-12-31
Free cash flowUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Gross marginUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Operating margin0.6%5.6%14.9%16.4%16.7%14.8%13.4%14.6%15.5%14.1%
FCF marginUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
SBC / revenue1.8%1.7%1.7%1.9%2.0%1.9%2.2%2.1%2.4%2.6%
Current ratio1.29x1.41x1.52x1.32x1.23x1.43x1.44x1.61x1.78x1.53x
Revenue YoY growth-0.9%-1.9%3.9%12.3%21.1%11.5%15.7%22.0%10.5%Unavailable
Net margin-3.6%0.5%11.5%12.2%11.0%12.5%9.6%10.0%6.6%9.2%
R&D / revenueUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
CapEx / revenueUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Long-term debt / equity0.67xUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Effective tax rateUnavailable72.8%17.4%20.9%17.0%18.3%16.5%19.3%57.7%30.0%

Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open CRL in the interactive workspace to inspect any figure back to its filing.

Source filings

10-Q · Filed 2026-08-05View SEC filing
10-Q · Filed 2026-05-07View SEC filing
10-K · Filed 2026-02-18View SEC filing
10-Q · Filed 2025-11-05View SEC filing
10-Q · Filed 2025-08-06View SEC filing
10-Q · Filed 2025-05-07View SEC filing

Companies in the same industry

Reconciliation checks needing review

2 periods on this page do not reconcile under this site’s normalization. Read that as a limitation here before an observation about the company: the figures are the filer’s own, the filings linked above are authoritative, and a difference usually means the concepts this site selected do not match how this filer presents its statements. Nothing is adjusted to make a check pass.

gross profit bridgeinconsistent2017-12-30

Withheld: gross profit could not be reconciled with the rest of this filer’s statement.

gross profit bridgeinconsistent2016-12-31

Withheld: gross profit could not be reconciled with the rest of this filer’s statement.